
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PHAR | Amsterdam | EUR | Real-time | |
PHARMa | BATS Europe | EUR | Delayed | |
PHAR | NASDAQ | USD | Real-time | |
PHGN | Frankfurt | EUR | Delayed |
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.
Name | Age | Since | Title |
---|---|---|---|
Paul J. Sekhri | 63 | 2015 | Independent Non-Executive Chairman |
Debora A. Jorn | 63 | 2019 | Independent Non-Executive Vice-Chairperson |
Sijmen de Vries | 62 | 2008 | President, CEO & Executive Director |
Barbara Yanni | 68 | 2020 | Independent Non-Executive Director |
Leonard Kruimer | 64 | 2021 | Independent Non-Executive Director |
Mark Jerome Pykett | 58 | 2020 | Independent Non-Executive Director |
Jabine van der Meijs | 56 | 2021 | Independent Non-Executive Director |
Steven Baert | 48 | 2021 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review